Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia

Prostate cancer (PCa) is one of the most commonly diagnosed cancers in the western world, and the mortality rate from PCa in Asia has been increasing recently. Statins are potent inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase and are commonly used for treating hyperlipidemi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Pharmacol
Glavni autori: Chen, Yu-An, Lin, Ying-Ju, Lin, Cheng-Li, Lin, Hwai-Jeng, Wu, Hua-Shan, Hsu, Hui-Ying, Sun, Yu-Chen, Wu, Hui-Yu, Lai, Chih-Ho, Kao, Chia-Hung
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2018
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5874326/
https://ncbi.nlm.nih.gov/pubmed/29623039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00225
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items